Drug Price Hikes in 2026: Hundreds of Drugs Increasing Despite Trump Administration Deals

Planned Drug Price Increases

• 📈 Drugmakers are planning to raise US list prices on at least 350 brand-name drugs in 2026.
• ⚠️ This price increase is set to occur despite previous pledges to offer reduced prices under new Trump administration policies.
• 💰 The average price jump is expected to be around 4%, marking the second consecutive year of such increases.

Prominent Drugs Facing Price Hikes

• 💉 Among the drugs slated for price increases are Pfizer's COVID vaccine, breast cancer treatment, and migraine medication.
• 🏥 Other affected medications include GSK's shingles vaccine and hospital-administered pain relievers like morphine and hydromorphone.
• 💊 Pfizer leads with hikes on approximately 80 medications, including those for cancer, COVID, and hospital use.

Manufacturer Justifications and Previous Agreements

• 🔬 Pfizer stated that price hikes are below the rate of inflation and will help cover rising costs and research.
• 🤝 This comes despite President Trump's claims that companies like Pfizer agreed to provide popular medications at heavily discounted prices.
• 🌍 Several companies that agreed to 'most favored nation' pricing, meaning Americans would pay the lowest global price, are still raising their prices.

Limited Good News and Broader Context

• ✅ A small number of drugs, specifically nine medications, will see price reductions, including the diabetes drug Jardiance.
• 🌎 However, Americans still pay nearly three times more for prescription drugs compared to patients in other wealthy countries.